Akimitsu Maeda
Nagoya, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team.
Journal: International journal of clinical oncology
Published: January 09, 2026
Investigation of the association between therapeutic effectiveness of anamorelin and Glasgow prognostic score in patients with cancer cachexia: a competing risk analysis.
Journal: Investigational new drugs
Published: November 11, 2024
Impact of ABCB1 single-nucleotide variants on early, extremely severe neutropenia induced by paclitaxel/nanoparticle albumin-bound paclitaxel in patients with gastric cancer.
Journal: British journal of clinical pharmacology
Published: September 28, 2024
Proposal for Classifying the Emetogenicity of Oral Anticancer Agents with a Focus on PARP Inhibitors: A Prospective, Observational, Multicenter Study (JASCC-CINV 2002).
Journal: Journal of Cancer
Published: October 30, 2023
Assessing floor contamination by antineoplastic agents in a Japanese medical institution specializing in cancer treatment.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: July 25, 2023
Effects of ABCB1 and ABCG2 Polymorphisms on the Pharmacokinetics of Abemaciclib Metabolites (M2, M20, M18).
Journal: Anticancer research
Published: October 10, 2022
Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer.
Journal: European journal of clinical pharmacology
Published: May 20, 2022
Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib.
Journal: European journal of clinical pharmacology
Published: January 17, 2022
Effects of 5-mg dose of olanzapine for breakthrough nausea and vomiting in patients receiving carboplatin-based chemotherapy: a prospective trial.
Journal: Annals of palliative medicine
Published: September 08, 2020
Serum concentration of the CKD4/6 inhibitor abemaciclib, but not of creatinine, strongly predicts hematological adverse events in patients with breast cancer: a preliminary report.
Journal: Investigational new drugs
Published: June 25, 2020
Associations among regorafenib concentrations, severe adverse reactions, and ABCG2 and OATP1B1 polymorphisms.
Journal: Cancer chemotherapy and pharmacology
Published: September 24, 2018
Differences in Urinary Renal Failure Biomarkers in Cancer Patients Initially Treated with Cisplatin.
Differences in Urinary Renal Failure Biomarkers in Cancer Patients Initially Treated with Cisplatin.
Journal: Anticancer research
Published: June 21, 2017
Last Updated: 09/26/2026